SARS-CoV-2 transmission in students of public schools of Catalonia (Spain) after a month of reopening.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 22 01 2021
accepted: 29 04 2021
entrez: 12 5 2021
pubmed: 13 5 2021
medline: 10 6 2021
Statut: epublish

Résumé

SARS-CoV-2 transmission within schools and its contribution to community transmission are still a matter of debate. A retrospective cohort study in all public schools in Catalonia was conducted using publicly available data assessing the association between the number of reported SARS-CoV-2 cases among students and staff in weeks 1-2 (Sept 14-27th, 2020) of the academic year with school SARS-CoV-2 incidence among students in weeks 4-5. A multilevel Poisson regression model adjusted for the community incidence in the corresponding basic health area (BHA) and the type of school (primary or secondary), with random effects at the sanitary region and BHA levels, was performed. A total of 2184 public schools opened on September 14th with 778,715 students. Multivariate analysis showed a significant association between the total number of SARS-CoV-2 cases in a centre in weeks 1-2 and the SARS-CoV-2 school incidence among students in weeks 4-5 (Risk Ratio (RR) 1.074, 95% CI 1.044-1.105, p-value <0.001). The adjusted BHA incidence in the first two weeks was associated with school incidence in weeks 4-5 (RR 1.002, 95% CI 1.002-1.003, p-value <0.001). Secondary schools showed an increased incidence in weeks 4 and 5 (RR primary vs secondary 1.709 95% CI 1.599-1.897, p-value <0.001). Safety measures adopted by schools were not enough to stop related-to-school transmission in students and could be improved. The safest way to keep schools open is to reduce community transmission down to a minimum.

Identifiants

pubmed: 33979410
doi: 10.1371/journal.pone.0251593
pii: PONE-D-21-02405
pmc: PMC8115831
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0251593

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Science. 2021 Feb 19;371(6531):
pubmed: 33323424
MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1631-1634
pubmed: 33151916
Med J Aust. 2020 Nov;213(10):444-446.e1
pubmed: 33099775
Science. 2020 Nov 6;370(6517):691-697
pubmed: 33154136
Gac Sanit. 2021 May-Jun;35(3):302-303
pubmed: 33162227
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33574041
Science. 2020 Sep 4;369(6508):1146
pubmed: 32883837
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Pediatrics. 2020 Aug;146(2):
pubmed: 32457212
Med. 2021 Feb 12;2(2):149-163.e4
pubmed: 33163984
BMJ. 2021 Mar 18;372:n628
pubmed: 33737413
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
Euro Surveill. 2020 Jul;25(29):
pubmed: 32720636
Lancet. 2021 Mar 27;397(10280):1177-1178
pubmed: 33713595
Nat Hum Behav. 2020 Dec;4(12):1303-1312
pubmed: 33199859
Rev Esp Salud Publica. 2020 Jul 27;94:
pubmed: 32713937
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Front Pediatr. 2021 Jan 14;8:615894
pubmed: 33520898
JAMA. 2020 Sep 1;324(9):859-870
pubmed: 32745200
Lancet Child Adolesc Health. 2020 Nov;4(11):817-827
pubmed: 32758453
Clin Infect Dis. 2021 Jul 15;73(2):e458-e465
pubmed: 32649743
Science. 2021 Jan 15;371(6526):
pubmed: 33234698
BMJ. 2020 Nov 12;371:m4352
pubmed: 33184048
Clin Infect Dis. 2021 Sep 15;73(6):e1261-e1269
pubmed: 33709135
Clin Infect Dis. 2021 Jun 15;72(12):e970-e977
pubmed: 33180914
Arch Pediatr. 2020 Oct;27(7):388-392
pubmed: 32921531
BMJ. 2021 Feb 23;372:n521
pubmed: 33622685
Lancet Infect Dis. 2021 Feb;21(2):193-202
pubmed: 33729915

Auteurs

Anna Llupià (A)

Department of Preventive Medicine and Epidemiology, Hospital Clínic, Barcelona, Spain.
Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
School of Medicine, Universitat de Barcelona, Barcelona, Spain.

Alícia Borràs-Santos (A)

Gimbernat School of Nursing, Universitat Autònoma de Barcelona (UAB), Sant Cugat del Vallès, Barcelona, Spain.

Caterina Guinovart (C)

Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.

Mireia Utzet (M)

Center for Research in Occupational Health (CISAL), Barcelona, Spain.
Universitat Pompeu Fabra, CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

David Moriña (D)

Department of Econometrics, Statistics and Applied Econometrics, Riskcenter-IREA, Universitat de Barcelona, Barcelona, Spain.

Joaquim Puig (J)

Department of Mathematics, Universitat Politècnica de Catalunya, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH